Tango Therapeutics, Inc.
TNGX
$1.29
$0.010.78%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.45% | -31.01% | -23.38% | -35.37% | -5.86% |
| Total Depreciation and Amortization | 0.49% | 1.47% | 4.64% | 7.57% | 8.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 120.18% | 6.14% | 41.92% | 48.87% | -18.40% |
| Change in Net Operating Assets | -852.93% | 26.47% | 37.03% | 41.55% | 81.15% |
| Cash from Operations | -33.42% | -7.24% | 3.54% | -8.45% | 2.83% |
| Capital Expenditure | 45.13% | -618.75% | 51.81% | 68.55% | 78.29% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 53.13% | 157.70% | -60.96% | -134.22% | 394.69% |
| Cash from Investing | 53.79% | 157.48% | -61.15% | -135.51% | 368.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -43.27% | -97.01% | 123.72% | 58,779.45% | 224.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -33.95% | -97.01% | 123.72% | 58,779.45% | 178.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 108.63% | 121.04% | -209.06% | -85.14% | 119.46% |